Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events

JACC: Cardiovascular Imaging

Volumn 6, Issue 12, 2013, Pages 1250-1259

  Figueroa, Amparo L ^a   Abdelbaky, Amr ^a   Truong, Quynh A ^a   Corsini, Erin ^a   MacNabb, Megan H ^a   Lavender, Zachary R ^a   Lawler, Meredith A ^a   Grinspoon, Steven K ^a   Brady, Thomas J ^a   Nasir, Khurram ^b,c   Hoffmann, Udo ^a   Tawakol, Ahmed ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

cardiovascular events; FDG PET; inflammation; risk factors

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; ASCENDING AORTA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY CALCIUM SCORE; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HIGH RISK PATIENT; HUMAN; INCIDENTAL FINDING; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PREDICTION; PRIORITY JOURNAL; RADIOGRAPHY DEVICE;

(18)F-FDG-PET; (18)F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY; CAC; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EVENTS; COMPUTED TOMOGRAPHY; CORONARY ARTERY CALCIUM; CT; CVD; FDG-PET; FRAMINGHAM RISK SCORE; FRS; HIGH-SENSITIVITY C-REACTIVE PROTEIN; HS-CRP; INFLAMMATION; NET RECLASSIFICATION INDEX; NRI; PAD; PERIPHERAL ARTERIAL DISEASE; RISK FACTORS; STANDARDIZED UPTAKE VALUE; SUV; TARGET-TO-BACKGROUND RATIO; TBR;

ADULT; AGED; ARTERITIS; BOSTON; DISEASE PROGRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; HOSPITALS, GENERAL; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR CALCIFICATION;

EID: 84890256598     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2013.08.006     Document Type: Article

References (40)

1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
2. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
3. P.W. Wilson, M. Pencina, P. Jacques, J. Selhub, R. D'Agostino Sr., and C.J. O'Donnell C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study Circ Cardiovasc Qual Outcomes 1 2008 92 97
4. T. Shah, J.P. Casas, and J.A. Cooper Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts Int J Epidemiol 38 2009 217 231
5. P.M. Ridker, J.E. Buring, N. Rifai, and N.R. Cook Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score JAMA 297 2007 611 619
6. E. Di Angelantonio, P. Gao, and L. Pennells Lipid-related markers and cardiovascular disease prediction JAMA 307 2012 2499 2506
7. O. Melander, C. Newton-Cheh, and P. Almgren Novel and conventional biomarkers for prediction of incident cardiovascular events in the community JAMA 302 2009 49 57
8. 18F-fluorodeoxyglucose positron emission tomography Circulation 105 2002 2708 2711
9. 18F- fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients J Am Coll Cardiol 48 2006 1818 1824
10. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease J Nucl Med 50 2009 1611 1620
11. B. Paulmier, M. Duet, and R. Khayat Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events J Nucl Cardiol 15 2008 209 217
12. R.B. D'Agostino Sr., R.S. Vasan, and M.J. Pencina General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 2008 743 753
13. S. Subramanian, A. Tawakol, and T.H. Burdo Arterial inflammation in patients with HIV JAMA 308 2012 379 386
14. 18Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials J Am Coll Cardiol 50 2007 892 896
15. 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations J Nucl Med 49 2008 871 878
16. M.A. Font, A. Fernandez, and A. Carvajal Imaging of early inflammation in low-to-moderate carotid stenosis by 18-FDG-PET Front Biosci 14 2009 3352 3360
17. M. Mizoguchi, N. Tahara, and A. Tahara Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta J Am Coll Cardiol Img 4 2011 1110 1118
18. M. Elkhawad, J.H. Rudd, and L. Sarov-Blat Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis J Am Coll Cardiol Img 5 2012 911 922
19. Z.A. Fayad, V. Mani, and M. Woodward Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial Lancet 378 2011 1547 1559
20. M.J. Blaha, M.J. Budoff, and A.P. DeFilippis Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study Lancet 378 2011 684 692
21. M. Gonen Analyzing Receiver Operating Characteristic Curves With SAS 2007 SAS Institute Inc. Cary, NC
22. M.J. Pencina, R.B. D'Agostino Sr., and E.W. Steyerberg Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers Stat Med 30 2011 11 21
23. L.J. Shaw, P. Raggi, E. Schisterman, D.S. Berman, and T.Q. Callister Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality Radiology 228 2003 826 833
24. A. Garedew, S.O. Henderson, and S. Moncada Activated macrophages utilize glycolytic ATP to maintain mitochondrial membrane potential and prevent apoptotic cell death Cell Death Differ 17 2010 1540 1550
25. T. Cramer, Y. Yamanishi, and B.E. Clausen HIF-1alpha is essential for myeloid cell-mediated inflammation Cell 112 2003 645 657
26. R. Kubota, K. Kubota, S. Yamada, M. Tada, T. Ido, and N. Tamahashi Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18- fluorodeoxyglucose uptake J Nucl Med 35 1994 104 112
27. T. Satomi, M. Ogawa, and I. Mori Comparison of contrast agents for atherosclerosis imaging using cultured macrophages: FDG versus ultrasmall superparamagnetic iron oxide J Nucl Med 54 2013 999 1004
28. M. Graebe, S.F. Pedersen, L. Borgwardt, L. Hojgaard, H. Sillesen, and A. Kjaer Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET) Eur J Vasc Endovasc Surg 37 2009 714 721
29. 18F-fluorodeoxyglucose positron emission tomography Arterioscler Thromb Vasc Biol 31 2011 944 949
30. 18F-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome J Am Coll Cardiol 49 2007 1533 1539
31. J.H. Rudd, K.S. Myers, and S. Bansilal Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study Circ Cardiovasc Imaging 2 2009 107 115
32. A.L. Figueroa, S.S. Subramanian, and R.C. Cury Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology Circ Cardiovasc Imaging 5 2012 69 77
33. I.S. Rogers, K. Nasir, and A.L. Figueroa Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina J Am Coll Cardiol Img 3 2010 388 397
34. 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging Stroke 36 2005 2642 2647
35. N. Tahara, H. Kai, and M. Ishibashi Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography J Am Coll Cardiol 48 2006 1825 1831
36. 18F-FDG PET/CT: when to image? J Nucl Med 50 2009 854 857
37. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
38. J.R. Carver, A. Ng, A.T. Meadows, and D.J. Vaughn Cardiovascular late effects and the ongoing care of adult cancer survivors Dis Manag 11 2008 1 6
39. M.J. Hooning, A. Botma, and B.M. Aleman Long-term risk of cardiovascular disease in 10-year survivors of breast cancer J Natl Cancer Inst 99 2007 365 375
40. A. Tawakol, Z.A. Fayad, and R. Mogg Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multi-center FDG-PET/CT feasibility study J Am Coll Cardiol 62 2013 909 917